These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8833928)

  • 1. [Use of synthetic antigens in studies of antigenic specificity of Proteus mirabilis 027 lipopolysaccharide].
    Krajewska-Pietrasik D; Cherniak AY; Rózalski A
    Med Dosw Mikrobiol; 1995; 47(3-4):169-76. PubMed ID: 8833928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and serological characterization of an Nepsilon-[(R)-1-carboxyethyl]-L-lysine-containing O-chain of the lipopolysaccharide of Proteus mirabilis O13.
    Swierzko AS; Cedzyński M; Ziółkowski A; Senchenkova SN; Perepelov AV; Knirel YA; Kaca W
    Arch Immunol Ther Exp (Warsz); 2001; 49(2):163-9. PubMed ID: 11348021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and serological classification of O-specific polysaccharide of Proteus mirabilisTG 276-90 from Proteus serogroup O34.
    Kołodziejska K; Siwińska M; Zych K; Rózalski A; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2006; 54(3):223-6. PubMed ID: 16736109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of Proteus mirabilis TG 115 and CCUG 10701 into the Proteus O23 serogroup based on chemical and serological studies of O-polysaccharides.
    Zabłotni A; Perepelov AV; Kołodziejska K; Zych K; Knirel YA; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2006; 54(6):411-7. PubMed ID: 17122881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and immunochemical studies on the lipopolysaccharide of the 'T-antigen'-containing mutant Proteus mirabilis R14/1959.
    Bartodziejska B; Radziejewska-Lebrecht J; Lipinska M; Knirel YA; Kononov LO; Chernyak AY; Mayer H; Rozalski A
    FEMS Immunol Med Microbiol; 1996 Feb; 13(2):113-21. PubMed ID: 8731019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotyping of clinical isolates belonging to Proteus mirabilis serogroup O36 and structural elucidation of the O36-antigen polysaccharide.
    Arabski M; Grabowski S; Konieczna I; Kaca W; Kondakova AN; Perepelov AV; Senchenkova SN; Shashkov AS; Knirel YA
    FEMS Immunol Med Microbiol; 2008 Aug; 53(3):395-403. PubMed ID: 18625011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the O-polysaccharide of Proteus mirabilis O19 and reclassification of certain Proteus strains that were formerly classified in serogroup O19.
    Perepelov AV; Rózalski A; Bartodziejska B; Senchenkova SN; Knirel YA
    Arch Immunol Ther Exp (Warsz); 2004; 52(3):188-96. PubMed ID: 15247885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the O-polysaccharide of Proteus mirabilis CCUG 10705 (OF) containing an amide of D-galacturonic acid with L-alanine.
    Perepelov AV; Zabłotni A; Shashkov AS; Knirel YA; Sidorczyk Z
    Carbohydr Res; 2006 Aug; 341(11):1969-74. PubMed ID: 16697996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and serological studies of the O-antigen of the bacterium Proteus mirabilis OXK (serogroup O3) used in the Weil-Felix test.
    Swierzko AS; Cedzynski M; Knirel YuA ; Senchenkova SN; Kocharova NA; Shashkov AS; Amano KI; Kyohno K; Kaca W
    Biochemistry (Mosc); 1997 Jan; 62(1):21-7. PubMed ID: 9113725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical studies on the O-antigens of Proteus mirabilis O23 and Proteus vulgaris O23.
    Rózalski A; Perepelov AV; Bartodziejska B; Senchenkova SN; Babicka D; Kaca W; Knirel YA
    Arch Immunol Ther Exp (Warsz); 2003; 51(1):69-74. PubMed ID: 12691306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures and serology of the O-antigens of Proteus strains classified into serogroup O17 and former serogroup O35.
    Torzewska A; Grabowski S; Kondakova AN; Toukach FV; Senchenkova SN; Shashkov AS; Arbatsky NP; Knirel YA; Rózalski A; Kaca W
    Arch Immunol Ther Exp (Warsz); 2006; 54(4):277-82. PubMed ID: 16868723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and serological properties of the O-antigen of two clinical Proteus mirabilis strains classified into a new Proteus O77 serogroup.
    Drzewiecka D; Arbatsky NP; Shashkov AS; Staczek P; Knirel YA; Sidorczyk Z
    FEMS Immunol Med Microbiol; 2008 Nov; 54(2):185-94. PubMed ID: 18665848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human anti-scrub typhus rickettsia and rabbit anti-Proteus antibodies recognize similar epitope in the O-polysaccharide part of Proteus mirabilis OXK lipopolysaccharide.
    Kaca W; Amano K; Chernyak AY; Knirel YA
    Microbios; 2000; 103(406):151-61. PubMed ID: 11131808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and epitope characterisation of the O-specific polysaccharide of Proteus mirabilis O28 containing amides of D-galacturonic acid with L-serine and L-lysine.
    Radziejewska-Lebrecht J; Shashkov AS; Vinogradov EV; Grosskurth H; Bartodziejska B; Rozalski A; Kaca W; Kononov LO; Chernyak AY; Mayer H
    Eur J Biochem; 1995 Jun; 230(2):705-12. PubMed ID: 7541753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological characterization of the O-specific polysaccharide of Providencia alcalifaciens O23.
    Torzewska A; Kocharova NA; Maszewska A; Knirel YA; Rózalski A
    Arch Immunol Ther Exp (Warsz); 2004; 52(1):43-9. PubMed ID: 15053232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies of epitope specificity of polyclonal antibodies against Proteus mirabilis R mutants].
    Bartodziejska B; Radziejewska-Lebrecht J; Lipińska M; Ziółkowski A; Rózalski A
    Med Dosw Mikrobiol; 1993; 45(1):99-102. PubMed ID: 7694017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures of the O-specific polysaccharides and a serological cross-reactivity of the lipopolysaccharides of Proteus mirabilis O24 and O29.
    Literacka E; Perepelov AV; Senchenkova SN; Zatonsky GV; Shashkov AS; Knirel YA; Kaca W
    FEBS Lett; 1999 Aug; 456(2):227-31. PubMed ID: 10456314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotyping of Proteus mirabilis clinical strains based on lipopolysaccharide O-polysaccharide and core oligosaccharide structures.
    Kaca W; Glenska J; Lechowicz L; Grabowski S; Brauner A; Kwinkowski M
    Biochemistry (Mosc); 2011 Jul; 76(7):851-61. PubMed ID: 21999547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the O-polysaccharide and serological studies of the lipopolysaccharide of Proteus mirabilis 2002.
    Perepelov AV; Zabłotni A; Shashkov AS; Knirel YA; Sidorczyk Z
    Carbohydr Res; 2005 Oct; 340(14):2305-10. PubMed ID: 16084933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the glycerol phosphate-containing O-polysaccharides and serological studies of the lipopolysaccharides of Proteus mirabilis CCUG 10704 (OE) and Proteus vulgaris TG 103 classified into a new Proteus serogroup, O54.
    Kołodziejska K; Perepelov AV; Zabłotni A; Drzewiecka D; Senchenkova SN; Zych K; Shashkov AS; Knirel YA; Sidorczyk Z
    FEMS Immunol Med Microbiol; 2006 Jul; 47(2):267-74. PubMed ID: 16831214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.